Holen Sie sich die Stockscreener-App
0.295
6.23%
-0.0196
Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
18.22%
1.9021
|
2.3259 | 2.7779 | 1.933 | 1.6198 |
| Operating Income/Loss |
18.22%
-1.9021
|
-2.3259 | -2.7779 | -1.933 | -1.6198 |
| Nonoperating Income/Loss |
733.64%
-0.7793
|
0.123 | 0.1495 | 0.4849 | 7.779 |
| Income/Loss From Continuing Operations Before Tax |
21.72%
-2.6814
|
-2.2029 | -2.6284 | -1.4482 | 6.1592 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
21.72%
-2.6814
|
-2.2029 | -2.6284 | -1.4482 | 6.1592 |
|
Net Income/Loss
|
21.72%
-2.6814
|
-2.2029 | -2.6284 | -1.4482 | 6.1592 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
123.54%
1.0898
|
-4.629 | 6.2973 | 5.8123 | 2.2107 |
| Diluted Average Shares |
122.73%
1.0898
|
-4.7955 | 6.2973 | 5.8123 | 3.1359 |
| Basic Earnings Per Share |
156.25%
-2.46
|
-0.96 | -0.42 | -0.25 | 2.79 |
| Diluted Earnings Per Share |
161.70%
-2.46
|
-0.94 | -0.42 | -0.25 | 1.96 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):